Pfizer To Acquire Clinical-Stage Biotech Firm Arena Therapeutics For US$6.7 Billion
Pfizer Inc. (NYSE: PFE) announced on Monday the definitive agreement to acquire clinical stage biopharmaceutical firm Arena Therapeutics (Nasdaq: ARNA).
Read morePfizer Inc. (NYSE: PFE) announced on Monday the definitive agreement to acquire clinical stage biopharmaceutical firm Arena Therapeutics (Nasdaq: ARNA).
Read more